Progress of antibody–drug conjugates (ADCs) targeting c-Met in cancer therapy; insights from clinical and preclinical studies
Ali Hussein Mer, Yousef Mirzaei, Fatemeh Misamogooe, Nader Bagheri, Ahmadreza Bazyari, Zahra Keshtkaran, Anna Meyfour, Alireza Shahedi, Zahra Amirkhani, Ameneh Jafari, Nesa Barpour, Saeed Jahandideh, Behzad Rezaei, Yousef Nikmanesh, Meghdad Abdollahpour‐Alitappeh
Topics & Concepts
MedicineMonoclonal antibodyCancer researchC-MetTyrosine kinaseReceptor tyrosine kinaseCancerAntibody-drug conjugateDrugAntibodyTargeted therapyPharmacologyImmunologyInternal medicineReceptorHepatocyte growth factorLiver physiology and pathologyHER2/EGFR in Cancer ResearchPI3K/AKT/mTOR signaling in cancer